Synexus Clinical Research US, Inc.
Synexus Clinical Research US, Inc.
Chicago, Illinois, United States3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults | Filoviridae infectious disease, Infections, Marburg hemorrhagic fever, Mononegavirales infectious disease, RNA Virus Infections, monkey disease, non-human animal disease, non-human primate disease, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Phase 2 | 2026-09-10 | NCT06620003 | |
| Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Active, not recruiting | Phase 3 | 2026-08-07 | NCT06007183 | |
| A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults | Ebola Sudan Virus Disease | Active, not recruiting | Phase 2 | 2026-02-10 | NCT06803342 |